Last reviewed · How we verify

NCT07537920

Trans-septal Quilting Suturing vs Intranasal Silicone Splinting in Septoplasty

Active, enrolled NA Last updated 17 April 2026
What this trial tests

NA trial testing trans-septal quilting suturing in DNS in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
4 March 2026
Primary endpoint
3 May 2026
3 June 2026

Quick facts

Lead sponsorShahida Islam Medical Complex
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date4 March 2026
Primary completion3 May 2026
Estimated completion3 June 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Shahida Islam Medical Complex

Who can join

Adults 10 to 40, any sex, with DNS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is currently little data comparing intranasal silicone splinting versus trans-septal quilted suturing in terms of preventing problems following septoplasty. The purpose of this study is to compare the results of intranasal silicone splinting with trans-septal quilted suturing following septoplasty. After septoplasty, this study will give us a better procedure with fewer adverse effects. Based on the outcomes, we can then regularly use that specific approach in our general practice to treat these specific individuals in an effort to lower their morbidity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for DNS

Currently open trials in the same condition.

Other Shahida Islam Medical Complex trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07537920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing